AnalystsArthur He
Arthur He's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 4%
#173 out of 5510 analysts
Average Return
+40.09%
Win Rate
58%58 out of 100
Risk vs Reward
Poor
Good

Arthur He's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Nektar TherapeuticsNKTR
+475.26%$12.23$70.36
2025-03-13 -
2026-03-12
Buy
Nektar TherapeuticsNKTR
+424.01%$13.06$68.42
2025-02-25 -
2026-02-24
Buy
Poseida Therapeutics IncPSTX
+335.27%$2.16$9.38
2024-04-22 -
2024-11-26
Buy
Poseida Therapeutics IncPSTX
+294.12%$2.38$9.38
2024-10-30 -
2024-11-26
Buy
Poseida Therapeutics IncPSTX
+269.29%$2.54$9.38
2024-10-17 -
2024-11-26
Buy

Arthur He Analyst Color

Get additional color on Arthur He's coverage of popular stocks

Arthur He's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Imagenebio IncIMA
1Buy$28.00+451.18%Initiates Coverage On
23 days ago
Satellos Bioscience IncMSLE
4Buy$18.00+84.62%Reiterates
a month ago
Vera Therapeutics IncVERA
6Buy$90.00+156.78%Maintains
a month ago
Prime Medicine IncPRME
10Buy$8.00+155.59%Reiterates
a month ago
Solid Biosciences IncSLDB
12Buy$25.00+187.36%Maintains
3 months ago
Jade Biosciences IncJBIO
4Buy$55.00+207.43%Maintains
3 months ago
Nektar TherapeuticsNKTR
7Buy$185.00+165.19%Maintains
5 months ago
Adagene IncADAG
11Buy$7.00N/AMaintains
a year ago
Lava Therapeutics NvLVTX
11Hold$1.24N/AMaintains
a year ago
Aurinia Pharmaceuticals IncAUPH
1Buy$17.00N/AAssumes
a year ago
Adaptimmune Therapeutics PLCADAPY
6Buy$3.00N/AMaintains
a year ago
Bioatla IncBCAB
8HoldN/AN/AReiterates
a year ago
Hookipa Pharma IncHOOK
7HoldN/AN/ADowngrades
2 years ago
Poseida Therapeutics IncPSTX
17Hold$9.00N/ADowngrades
2 years ago
Calliditas Therapeutics AbCALT
4Hold$39.00N/ADowngrades
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.